Table of Content




Chapter 1. Methodology & Scope


1.1. Methodology


1.1.1. Initial data exploration


1.1.2. Statistical model and forecast


1.1.3. Industry insights and validation


1.1.4. Definitions & forecast parameters


1.2. Data sources


1.2.1. Secondary


1.2.2. Primary


Chapter 2. Executive Summary


2.1. Eye health ingredients market 3600 synopsis, 2013 –2024


2.1.1. Business trends


2.1.2. Source trends


2.1.3. Ingredient trends


2.1.4. Form trends


2.1.5. Application trends


2.1.6. Disease indication trends


2.1.7. Regional trends


Chapter 3. Eye Health Ingredients Industry Insights


3.1. Industry segmentation


3.2. Industry growth landscape, 2013 - 2024


3.3. Industry ecosystem analysis


3.3.1. Regional profit margin trends


3.3.1.1. North America


3.3.1.2. Europe


3.3.1.3. APAC


3.3.1.4. LATAM


3.3.1.5. MEA


3.3.2. Vendor matrix


3.3.2.1. Raw material suppliers


3.3.2.2. Ingredient manufacturers


3.3.2.3. Geographical footprint


3.3.2.4. Production capacity of key players


3.3.3. Distribution channel analysis


3.3.3.1. Supermarkets


3.3.3.2. Specialty retail


3.3.3.3. Pharmacy Chains


3.3.3.4. Independent Retailers


3.3.3.5. Internet/ home shopping


3.4. Regional pricing trends


3.4.1.1. North America


3.4.1.2. Europe


3.4.1.3. APAC


3.4.1.4. LATAM


3.4.1.5. MEA


3.5. Trade scenario


3.6. Regulatory landscape


3.6.1. Regulation of Color Additives


3.6.1.1. U.S.


3.6.1.2. Europe


3.6.1.3. China


3.6.1.4. APAC


3.7. Regional raw material trends


3.7.1. Lutein


3.7.2. Zeaxanthin


3.7.3. Beta Carotene


3.7.4. Vitamin A


3.7.5. Bilberry extracts


3.7.6. Others (Capsanthin, Annatto, Omega-3)


3.8. Industry impact forces


3.8.1. Growth drivers


3.8.1.1. Increasing consumer concerns around eye health


3.8.1.2. Nutraceutical industry expansion


3.8.1.3. Increasing AMD disease occurrence among geriatric population


3.8.1.4. Increase in healthcare expenditure leading consumer interest over OTC supplements


3.8.2. Industry pitfalls & challenges


3.8.2.1. Limited availability of lutein and zeaxanthin


3.8.2.2. Harmful health effects from carotenoid consumption


3.9. Eye health ingredients latest product launches


3.9.1. U.S.


3.9.2. Germany


3.9.3. Russia


3.9.4. India


3.9.5. UK


3.9.6. China


3.9.7. Brazil


3.9.8. South Africa


3.10. Growth potential analysis, 2016


3.11. Critical success factors


3.11.1. Role of industry associations


3.11.2. International demographics of declining vision


3.11.3. Consumer behavior towards eye health ingredients


3.11.4. OTC eye care supplements vs prescribed eyecare supplements


3.11.5. Regional consumer insights


3.11.5.1. North America


3.11.5.2. Europe


3.11.5.3. APAC


3.11.5.4. LATAM


3.11.5.5. MEA


3.12. Porter's analysis


3.13. Company market share analysis, 2016


3.13.1. Strategy dashboard


3.14. PESTEL analysis


Chapter 4. Eye Health Ingredients Market, By Source


4.1. Global eye health ingredients market share by source, 2016 & 2024


4.2. Natural


4.2.1. Market estimates and forecast, 2013 - 2024


4.2.2. Market estimates and forecast, by region, 2013–2024


4.3. Synthetic


4.3.1. Market estimates and forecast, 2013 - 2024


4.3.2. Market estimates and forecast, by region, 2013–2024


Chapter 5. Eye Health Ingredients Market, By Ingredient


5.1. Global eye health ingredients market share by ingredient, 2016 & 2024


5.2. Lutein


5.2.1. Market estimates and forecast, 2013 - 2024


5.2.2. Market estimates and forecast, by region, 2013–2024


5.3. Zeaxanthin


5.3.1. Market estimates and forecast, 2013 - 2024


5.3.2. Market estimates and forecast, by region, 2013–2024


5.4. Beta Carotene


5.4.1. Market estimates and forecast, 2013 - 2024


5.4.2. Market estimates and forecast, by region, 2013–2024


5.5. Vitamin A


5.5.1. Market estimates and forecast, 2013 - 2024


5.5.2. Market estimates and forecast, by region, 2013–2024


5.6. Bilberry extracts


5.6.1. Market estimates and forecast, 2013 - 2024


5.6.2. Market estimates and forecast, by region, 2013–2024


5.7. Others (Vitamin C, Vitamin E, Zinc & Omega-3 fatty acids, Astaxanthin)


5.7.1. Market estimates and forecast, 2013 - 2024


5.7.2. Market estimates and forecast, by region, 2013–2024


Chapter 6. Eye Health Ingredients Market, By Form


6.1. Global eye health ingredients market share by form, 2016 & 2024


6.2. Soft gel, capsule & tablets


6.2.1. Market estimates and forecast, 2013 - 2024


6.2.2. Market estimates and forecast, by region, 2013–2024


6.3. Liquid


6.3.1. Market estimates and forecast, 2013 - 2024


6.3.2. Market estimates and forecast, by region, 2013–2024


6.4. Powder


6.4.1. Market estimates and forecast, 2013 - 2024


6.4.2. Market estimates and forecast, by region, 2013–2024


Chapter 7. Eye Health Ingredients Market, By Application


7.1. Global eye health ingredients market share by application, 2016 & 2024


7.2. Human


7.2.1. Market estimates and forecast, 2013 - 2024


7.2.2. Market estimates and forecast, by region, 2013–2024


7.3. Animal


7.3.1. Market estimates and forecast, 2013 - 2024


7.3.2. Market estimates and forecast, by region, 2013–2024


Chapter 8. Eye Health Ingredients Market, By Disease Indication


8.1. Global eye health ingredients market share by disease indication, 2016 & 2024


8.2. Age related macular degeneration


8.2.1. Market estimates and forecast, 2013 - 2024


8.2.2. Market estimates and forecast, by region, 2013–2024


8.3. Cataract


8.3.1. Market estimates and forecast, 2013 - 2024


8.3.2. Market estimates and forecast, by region, 2013–2024


8.4. Dry eye syndrome


8.4.1. Market estimates and forecast, 2013 - 2024


8.4.2. Market estimates and forecast, by region, 2013–2024


8.5. Other indications


8.5.1. Market estimates and forecast, 2013 - 2024


8.5.2. Market estimates and forecast, by region, 2013–2024


Chapter 9. Eye Health Ingredients Market, By Region


9.1. Global eye health ingredients market share by region, 2016 & 2024


9.2. North America


9.2.1. Market estimates and forecast, 2013 – 2024


9.2.2. Market estimates and forecast, by source, 2013 – 2024


9.2.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.2.4. Market estimates and forecast, by form, 2013 – 2024


9.2.5. Market estimates and forecast, by application, 2013 – 2024


9.2.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.2.7. U.S.


9.2.7.1. Market estimates and forecast, 2013 – 2024


9.2.7.2. Market estimates and forecast, by source, 2013 – 2024


9.2.7.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.2.7.4. Market estimates and forecast, by form, 2013 – 2024


9.2.7.5. Market estimates and forecast, by application, 2013 – 2024


9.2.7.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.2.8. Canada


9.2.8.1. Market estimates and forecast, 2013 – 2024


9.2.8.2. Market estimates and forecast, by source, 2013 – 2024


9.2.8.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.2.8.4. Market estimates and forecast, by form, 2013 – 2024


9.2.8.5. Market estimates and forecast, by application, 2013 – 2024


9.2.8.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.3. Europe


9.3.1. Market estimates and forecast, 2013 – 2024


9.3.2. Market estimates and forecast, by source, 2013 – 2024


9.3.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.3.4. Market estimates and forecast, by form, 2013 – 2024


9.3.5. Market estimates and forecast, by application, 2013 – 2024


9.3.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.3.7. Germany


9.3.7.1. Market estimates and forecast, 2013 – 2024


9.3.7.2. Market estimates and forecast, by source, 2013 – 2024


9.3.7.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.3.7.4. Market estimates and forecast, by form, 2013 – 2024


9.3.7.5. Market estimates and forecast, by application, 2013 – 2024


9.3.7.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.3.8. UK


9.3.8.1. Market estimates and forecast, 2013 – 2024


9.3.8.2. Market estimates and forecast, by source, 2013 – 2024


9.3.8.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.3.8.4. Market estimates and forecast, by form, 2013 – 2024


9.3.8.5. Market estimates and forecast, by application, 2013 – 2024


9.3.8.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.3.9. France


9.3.9.1. Market estimates and forecast, 2013 – 2024


9.3.9.2. Market estimates and forecast, by source, 2013 – 2024


9.3.9.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.3.9.4. Market estimates and forecast, by form, 2013 – 2024


9.3.9.5. Market estimates and forecast, by application, 2013 – 2024


9.3.9.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.3.10. Italy


9.3.10.1. Market estimates and forecast, 2013 – 2024


9.3.10.2. Market estimates and forecast, by source, 2013 – 2024


9.3.10.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.3.10.4. Market estimates and forecast, by form, 2013 – 2024


9.3.10.5. Market estimates and forecast, by application, 2013 – 2024


9.3.10.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.3.11. Russia


9.3.11.1. Market estimates and forecast, 2013 – 2024


9.3.11.2. Market estimates and forecast, by source, 2013 – 2024


9.3.11.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.3.11.4. Market estimates and forecast, by form, 2013 – 2024


9.3.11.5. Market estimates and forecast, by application, 2013 – 2024


9.3.11.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.4. Asia Pacific


9.4.1. Market estimates and forecast, 2013 – 2024


9.4.2. Market estimates and forecast, by source, 2013 – 2024


9.4.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.4.4. Market estimates and forecast, by form, 2013 – 2024


9.4.5. Market estimates and forecast, by application, 2013 – 2024


9.4.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.4.7. China


9.4.7.1. Market estimates and forecast, 2013 – 2024


9.4.7.2. Market estimates and forecast, by source, 2013 – 2024


9.4.7.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.4.7.4. Market estimates and forecast, by form, 2013 – 2024


9.4.7.5. Market estimates and forecast, by application, 2013 – 2024


9.4.7.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.4.8. India


9.4.8.1. Market estimates and forecast, 2013 – 2024


9.4.8.2. Market estimates and forecast, by source, 2013 – 2024


9.4.8.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.4.8.4. Market estimates and forecast, by form, 2013 – 2024


9.4.8.5. Market estimates and forecast, by application, 2013 – 2024


9.4.8.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.4.9. South Korea


9.4.9.1. Market estimates and forecast, 2013 – 2024


9.4.9.2. Market estimates and forecast, by source, 2013 – 2024


9.4.9.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.4.9.4. Market estimates and forecast, by form, 2013 – 2024


9.4.9.5. Market estimates and forecast, by application, 2013 – 2024


9.4.9.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.4.10. Japan


9.4.10.1. Market estimates and forecast, 2013 – 2024


9.4.10.2. Market estimates and forecast, by source, 2013 – 2024


9.4.10.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.4.10.4. Market estimates and forecast, by form, 2013 – 2024


9.4.10.5. Market estimates and forecast, by application, 2013 – 2024


9.4.10.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.5. Latin America


9.5.1. Market estimates and forecast, 2013 – 2024


9.5.2. Market estimates and forecast, by source, 2013 – 2024


9.5.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.5.4. Market estimates and forecast, by form, 2013 – 2024


9.5.5. Market estimates and forecast, by application, 2013 – 2024


9.5.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.5.7. Brazil


9.5.7.1. Market estimates and forecast, 2013 – 2024


9.5.7.2. Market estimates and forecast, by source, 2013 – 2024


9.5.7.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.5.7.4. Market estimates and forecast, by form, 2013 – 2024


9.5.7.5. Market estimates and forecast, by application, 2013 – 2024


9.5.7.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.5.8. Mexico


9.5.8.1. Market estimates and forecast, 2013 – 2024


9.5.8.2. Market estimates and forecast, by source, 2013 – 2024


9.5.8.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.5.8.4. Market estimates and forecast, by form, 2013 – 2024


9.5.8.5. Market estimates and forecast, by application, 2013 – 2024


9.5.8.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.5.9. Argentina


9.5.9.1. Market estimates and forecast, 2013 – 2024


9.5.9.2. Market estimates and forecast, by source, 2013 – 2024


9.5.9.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.5.9.4. Market estimates and forecast, by form, 2013 – 2024


9.5.9.5. Market estimates and forecast, by application, 2013 – 2024


9.5.9.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.6. Middle East & Africa (MEA)


9.6.1. Market estimates and forecast, 2013 – 2024


9.6.2. Market estimates and forecast, by source, 2013 – 2024


9.6.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.6.4. Market estimates and forecast, by form, 2013 – 2024


9.6.5. Market estimates and forecast, by application, 2013 – 2024


9.6.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.6.7. Saudi Arabia


9.6.7.1. Market estimates and forecast, 2013 – 2024


9.6.7.2. Market estimates and forecast, by source, 2013 – 2024


9.6.7.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.6.7.4. Market estimates and forecast, by form, 2013 – 2024


9.6.7.5. Market estimates and forecast, by application, 2013 – 2024


9.6.7.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.6.8. UAE


9.6.8.1. Market estimates and forecast, 2013 – 2024


9.6.8.2. Market estimates and forecast, by source, 2013 – 2024


9.6.8.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.6.8.4. Market estimates and forecast, by form, 2013 – 2024


9.6.8.5. Market estimates and forecast, by application, 2013 – 2024


9.6.8.6. Market estimates and forecast, by disease indication, 2013 – 2024


9.6.9. South Africa


9.6.9.1. Market estimates and forecast, 2013 – 2024


9.6.9.2. Market estimates and forecast, by source, 2013 – 2024


9.6.9.3. Market estimates and forecast, by ingredient, 2013 – 2024


9.6.9.4. Market estimates and forecast, by form, 2013 – 2024


9.6.9.5. Market estimates and forecast, by application, 2013 – 2024


9.6.9.6. Market estimates and forecast, by disease indication, 2013 – 2024


Chapter 10. Company Profiles


10.1. Allied Biotech Corporation


10.1.1. Business Overview


10.1.2. Financial Data


10.1.3. Concentrations Landscape


10.1.4. Strategic Outlook


10.1.5. SWOT Analysis


10.2. BASF


10.2.1. Business Overview


10.2.2. Financial Data


10.2.3. Concentrations Landscape


10.2.4. Strategic Outlook


10.2.5. SWOT Analysis


10.3. DSM


10.3.1. Business Overview


10.3.2. Financial Data


10.3.3. Concentrations Landscape


10.3.4. Strategic Outlook


10.3.5. SWOT Analysis


10.4. Kemin


10.4.1. Business Overview


10.4.2. Financial Data


10.4.3. Concentrations Landscape


10.4.4. Strategic Outlook


10.4.5. SWOT Analysis


10.5. Tianjin Pharmaland Technology


10.5.1. Business Overview


10.5.2. Financial Data


10.5.3. Concentrations Landscape


10.5.4. Strategic Outlook


10.5.5. SWOT Analysis


10.6. American River Nutrition, Inc


10.6.1. Business Overview


10.6.2. Financial Data


10.6.3. Concentrations Landscape


10.6.4. Strategic Outlook


10.6.5. SWOT Analysis


10.7. Archer Daniels Midland Company


10.7.1. Business Overview


10.7.2. Financial Data


10.7.3. Concentrations Landscape


10.7.4. Strategic Outlook


10.7.5. SWOT Analysis


10.8. Vitae Naturals


10.8.1. Business Overview


10.8.2. Financial Data


10.8.3. Concentrations Landscape


10.8.4. Strategic Outlook


10.8.5. SWOT Analysis


10.9. Davos life Science


10.9.1. Business Overview


10.9.2. Financial Data


10.9.3. Concentrations Landscape


10.9.4. Strategic Outlook


10.9.5. SWOT Analysis


10.10. Cargil


10.10.1. Business Overview


10.10.2. Financial Data


10.10.3. Concentrations Landscape


10.10.4. Strategic Outlook


10.10.5. SWOT Analysis


10.11. Wilmer Spring Fruit Nutrition Products Co. Ltd


10.11.1. Business Overview


10.11.2. Financial Data


10.11.3. Concentrations Landscape


10.11.4. Strategic Outlook


10.11.5. SWOT Analysis


10.12. FMC corporation


10.12.1. Business Overview


10.12.2. Financial Data


10.12.3. Concentrations Landscape


10.12.4. Strategic Outlook


10.12.5. SWOT Analysis